Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,863 | -30,835 | -104,126 | -86,712 | -55,054 |
| Depreciation Amortization | 1,223 | 644 | 2,863 | 2,194 | 1,618 |
| Accounts receivable | 509 | 319 | 588 | 483 | 364 |
| Accounts payable and accrued liabilities | 2,692 | -1,876 | 3,119 | 6,684 | 2,251 |
| Other Working Capital | 477 | -3,498 | 4,973 | 6,373 | 2,314 |
| Other Operating Activity | 1,988 | 4,927 | 1,504 | 1,640 | 3,104 |
| Operating Cash Flow | $-49,974 | $-30,319 | $-91,079 | $-69,338 | $-45,403 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,313 | 39,787 | 101,135 | 61,171 | 40,669 |
| PPE Investments | 1,478 | 781 | -1,591 | -1,398 | -1,136 |
| Investing Cash Flow | $41,791 | $40,568 | $99,544 | $59,773 | $39,533 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -839 | -420 | -1,574 | -1,167 | -773 |
| Common Stock Issued | 162 | 76 | 1,084 | 874 | 347 |
| Common Stock Repurchased | -887 | -887 | -873 | -873 | -873 |
| Other Financing Activity | -27 | 0 | -26 | -111 | 0 |
| Financing Cash Flow | $-1,591 | $-1,231 | $-1,389 | $-1,277 | $-1,299 |
| Beginning Cash Position | 37,499 | 37,499 | 30,423 | 30,423 | 30,423 |
| End Cash Position | 27,725 | 46,517 | 37,499 | 19,581 | 23,254 |
| Net Cash Flow | $-9,774 | $9,018 | $7,076 | $-10,842 | $-7,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,974 | -30,319 | -91,079 | -69,338 | -45,403 |
| Capital Expenditure | -39 | -28 | -1,721 | -1,506 | -1,238 |
| Free Cash Flow | -50,013 | -30,347 | -92,800 | -70,844 | -46,641 |